2014-11-10T16:49:37-06:00 2013-12-31 ERNST & YOUNG US LLP 111 MONUMENT CIRCLE SUITE 4000 INDIANAPOLIS IN 46204 990 2013-01-01 912154267 Memorial Sloan-Kettering Cancer Center % MICHAEL P GUTNICK MEMO 6462273092 1275 York Avenue Suite New York NY 10065 MICHAEL P GUTNICK EXEC VP & CFO 2014-11-10 2013 2015-11-30 17:44:51Z CRAIG B THOMPSON MD 1275 York Avenue New York NY 10065 4014831094 true true 3475 X www.mskcc.org X LEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION , AND COST EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATION. 110 80 15020 1004 -2579730 -4306911 388184750 538157930 2234171000 2418623000 115503000 285796000 124279272 143514942 2862138022 3386091872 54974000 56370000 0 0 1532516541 1638636399 1309484 1346005 51613872 1176896997 1220593468 2765697022 2916945872 96441000 469146000 7795608000 8481418000 3562556000 3337444000 4233052000 5143974000 X MEMORIAL SLOAN-KETTERING CANCER CENTER IS DEDICATED TO THIS MISSION: LEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION, AND COST-EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATION. LEADERSHIP IN PATIENT CARE WE PLACE THE HIGHEST PRIORITY ON ADVANCING THE CARE OF CANCER PATIENTS THROUGH EARLY DETECTION, ACCURATE DIAGNOSIS, AND OPTIMAL TREATMENT. THESE THREE ELEMENTS LEAD TO THE MOST EFFECTIVE CANCER CARE POSSIBLE, WHICH IS ALSO THE MOST COST-EFFECTIVE CARE POSSIBLE. WE STRIVE FOR EXCELLENCE IN ALL EXISTING AND EMERGING THERAPIES WITHOUT NEGLECTING THE NEED FOR ADVANCED APPROACHES IN PALLIATION. WE DELIVER THESE THERAPIES IN A CARING ENVIRONMENT THAT ENCOMPASSES PATIENTS AS WELL AS THEIR LOVED ONES. EXCELLENCE IN PATIENT CARE IS EXEMPLIFIED BY OUR MULTIDISCIPLINARY APPROACH, A CORE COMPETENCE OF OUR CENTER. WE ARE COMMITTED TO DEVELOPING OUTREACH PROGRAMS TO BRING EXCELLENCE IN CANCER CARE TO THE COMMUNITY. LEADERSHIP IN RESEARC false false 2301166820 32593000 2377063000 PATIENT CARE MEMORIAL SLOAN-KETTERING CANCER CENTER EXPERTS HAVE ESTABLISHED STANDARDS OF CARE AND TREATMENT PROTOCOLS FOR EACH TYPE AND STAGE OF CANCER. OUR PHYSICIANS HAVE AN EXTRAORDINARY DEPTH AND BREADTH OF EXPERIENCE IN DIAGNOSING AND TREATING ALL FORMS OF THE DISEASE, FROM THE MOST COMMON TO THE VERY RARE. EACH YEAR, THEY TREAT MORE THAN 400 DIFFERENT SUBTYPES OF CANCER. THIS LEVEL OF SPECIALIZATION CAN HAVE AN OFTEN-DRAMATIC EFFECT ON A PATIENT'S CHANCES FOR A CURE OR CONTROL OF THEIR CANCER. WHILE WE ARE KNOWN FOR OUR ADVANCED, INNOVATIVE THERAPIES, OUR PHYSICIANS ARE EQUALLY WELL REGARDED FOR THEIR COMPASSION AND CONCERN. OUR DISEASE MANAGEMENT PROGRAM FEATURES 16 MULTIDISCIPLINARY CANCER TEAMS. PATIENTS ARE TREATED BY AS MANY DIFFERENT SPECIALISTS AS ARE NEEDED FOR THEIR PARTICULAR TYPE OF DISEASE, INCLUDING SURGEONS, MEDICAL ONCOLOGISTS, RADIATION ONCOLOGISTS, RADIOLOGISTS, PATHOLOGISTS, PSYCHIATRISTS, AND NURSES. OUR PATHOLOGISTS HAVE UNSURPASSED EXPERTISE IN USING ADVANCED METHODS TO ACCURATELY DIAGNOSE CANCER. BECAUSE OF THEIR SOLE FOCUS ON CANCER, OUR SURGEONS, USE SURGICAL TECHNIQUES THAT PRESERVE FORM AND FUNCTION. OUR RADIATION ONCOLOGISTS ARE DEVELOPING AND PUTTING INTO CLINICAL PRACTICE LEADING-EDGE TECHNOLOGIES AND TECHNIQUES IN RADIATION THERAPY. IN ADDITION, THE CENTER OFFERS A FULL RANGE OF PROGRAMS TO HELP PATIENTS AND FAMILIES THROUGHOUT ALL PHASES OF TREATMENT, INCLUDING SUPPORT GROUPS, GENETIC COUNSELING, HELP MANAGING CANCER PAIN AND SYMPTOMS, REHABILITATION, INTEGRATIVE MEDICINE SERVICES, AND ASSISTANCE IN NAVIGATING LIFE AFTER TREATMENT. 510275448 22807000 41560000 RESEARCH MEMORIAL SLOAN-KETTERING CANCER CENTER MAINTAINS ONE OF THE WORLD'S MOST DYNAMIC PROGRAMS OF CANCER RESEARCH. THE EXTRAORDINARY PATIENT CARE WE PROVIDE BENEFITS FROM OUR INNOVATIVE PROGRAMS IN BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH. RESEARCH AT SLOAN-KETTERING INSTITUTE IS DEDICATED TO UNDERSTANDING THE BIOLOGY OF CANCER THROUGH PROGRAMS IN CELL BIOLOGY, GENETICS, BIOCHEMISTRY, MOLECULAR BIOLOGY, STRUCTURAL BIOLOGY, COMPUTATIONAL BIOLOGY, IMMUNOLOGY, AND THERAPEUTICS. INVESTIGATORS AT SLOAN-KETTERING INSTITUTE COLLABORATE WITH MEMORIAL HOSPITAL PHYSICIAN-SCIENTISTS, A PARTNERSHIP THAT HELPS SPEED IMPORTANT RESEARCH FINDINGS FROM THE LABORATORY TO THE BEDSIDE, IN A PROCESS KNOWN AS TRANSLATIONAL RESEARCH. MEMORIAL SLOAN-KETTERING CANCER CENTER ALSO ACTIVELY INITIATES AND PARTICIPATES IN CLINICAL TRIALS TO IDENTIFY MORE EFFECTIVE CANCER THERAPIES, AND OUR PHYSICIANS ARE CURRENTLY LEADING 735 CLINICAL TRIALS FOR PEDIATRIC AND ADULT CANCERS. THE HUMAN ONCOLOGY AND PATHOGENESIS PROGRAM (HOPP) IS A FURTHER EFFORT TO INCREASE INSTITUTIONAL RESEARCH STRENGTH IN AREAS IMPORTANT IN CONTEMPORARY TRANSLATIONAL RESEARCH. HOPP IS DESIGNED TO MELD EVEN MORE THOROUGHLY THE CULTURES OF BASIC BIOLOGIC SCIENCE AND CLINICAL ONCOLOGY, AUGMENTING THE WORK CONDUCTED IN THE LABORATORIES OF MEMORIAL SLOAN-KETTERING CANCER CENTER'S PHYSICIAN-SCIENTISTS. 3027732 970000 GRADUATE SCHOOL OF BIOMEDICAL SCIENCE EDUCATION IS A VITAL PART OF MEMORIAL SLOAN-KETTERING CANCER CENTER'S MISSION. OUR TRAINING PROGRAMS PREPARE PHYSICIANS AND SCIENTISTS FOR CAREERS IN THE BIOMEDICAL SCIENCES. OUR COLLABORATIONS WITH THE ROCKEFELLER UNIVERSITY, CORNELL UNIVERSITY, AND WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY OFFER PHD PROGRAMS IN CHEMICAL BIOLOGY, COMPUTATIONAL BIOLOGY AND MEDICINE, AND THE MEDICAL SCIENCES. THE CENTER ALSO PARTNERS WITH WEILL MEDICAL COLLEGE AND THE ROCKEFELLER UNIVERSITY TO OFFER A MD/PHD DEGREE FOR ASPIRING PHYSICIAN-SCIENTISTS. IN 2004, THE CENTER ESTABLISHED A PHD PROGRAM IN CANCER BIOLOGY THROUGH ITS NEW LOUIS V. GERSTNER, JR. GRADUATE SCHOOL OF BIOMEDICAL SCIENCES. THIS NOVEL PROGRAM, WHICH ENROLLED ITS FIRST CLASS IN 2006, TRAINS BASIC LABORATORY SCIENTISTS TO WORK IN RESEARCH AREAS DIRECTLY RELEVANT TO CANCER AND OTHER HUMAN DISEASES. WE ALSO OFFER POSTGRADUATE CLINICAL FELLOWSHIPS TO TRAIN PHYSICIANS WHO SEEK SPECIAL EXPERTISE IN A PARTICULAR TYPE OF CANCER AND POSTGRADUATE RESEARCH FELLOWSHIPS THAT PROVIDE PHYSICIANS AND SCIENTISTS WITH ADVANCED LABORATORY RESEARCH TRAINING. WITH FACULTY APPOINTMENTS AT THE WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY, OUR CLINICAL STAFF ALSO TRAIN RESIDENTS AND MEDICAL STUDENTS. 2814470000 true true false true false false false false false true true true false false true false false true true false true false false true true false true true true true true true false false false false false true false false true true true false false false false true true true false false true 2072 0 true 15020 true true true false false false false true true false false false false X 110 80 false false false false false false false true true false false true true true true true true true true true true AK AZ AR FL GA IL KS LA MD MA MI MN MS MO NV NH NJ NM NY ND OH OK PA RI SC TN TX UT WA WI X X MICHAEL P GUTNICK 6462273413 633 3RD AVENUE NEW YORK NY 10017 X RICHARD I BEATTIE SEE SCHEDULE O 2.0 0.0 X 0 0 0 ANTHONY B EVNIN SEE SCHEDULE O 2.0 0.0 X 0 0 0 STANLEY F DRUCKENMILLER SEE SCHEDULE O 1.0 0.0 X 0 0 0 RICHARD N FOSTER SEE SCHEDULE O 2.0 0.0 X 0 0 0 STEPHEN FRIEDMAN SEE SCHEDULE O 2.0 0.0 X 0 0 0 ELLEN V FUTTER SEE SCHEDULE O 1.0 0.0 X 0 0 0 PHILIP H GEIER JR SEE SCHEDULE O 1.0 0.0 X 0 0 0 LOUIS V GERSTNER JR SEE SCHEDULE O 2.0 0.0 X 0 0 0 JONATHAN N GRAYER SEE SCHEDULE O 1.0 0.0 X 0 0 0 JOHN R GUNN SEE SCHEDULE O 50.0 0.0 X X 1677531 0 79815 MICHAEL P GUTNICK SEE SCHEDULE O 50.0 0.0 X X 1479588 0 86446 ANNETTE U RICKEL PHD SEE SCHEDULE O 2.0 0.0 X 0 0 0 BENJAMIN W HEINEMAN JR SEE SCHEDULE O 2.0 0.0 X 0 0 0 JEFFREY P JOHNSON SEE SCHEDULE O 1.0 0.0 X 0 0 0 VIRGINIA M ROMETTY SEE SCHEDULE O 2.0 0.0 X 0 0 0 DAVID H KOCH SEE SCHEDULE O 1.0 0.0 X 0 0 0 MARIE-JOSEE KRAVIS SEE SCHEDULE O 1.0 0.0 X 0 0 0 PETER J SOLOMON SEE SCHEDULE O 1.0 0.0 X 0 0 0 PETER A WEINBERG SEE SCHEDULE O 2.0 0.0 X 0 0 0 JAMES G NIVEN SEE SCHEDULE O 1.0 0.0 X 0 0 0 HUTHAM S OLAYAN SEE SCHEDULE O 1.0 0.0 X 0 0 0 BRUCE C RATNER SEE SCHEDULE O 1.0 0.0 X 0 0 0 CLIFTON S ROBBINS SEE SCHEDULE O 2.0 0.0 X X 0 0 0 JAMES D ROBINSON III SEE SCHEDULE O 1.0 0.0 X 0 0 0 BENJAMIN M ROSEN SEE SCHEDULE O 1.0 0.0 X 0 0 0 NORMAN C SELBY SEE SCHEDULE O 2.0 0.0 X X 0 0 0 STEPHEN C SHERRILL SEE SCHEDULE O 1.0 0.0 X 0 0 0 SCOTT M STUART SEE SCHEDULE O 1.0 0.0 X 0 0 0 MARK SVENNINGSON SEE SCHEDULE O 50.0 0.0 X X 717109 0 75345 LUCY R WALETZKY MD SEE SCHEDULE O 1.0 0.0 X 0 0 0 DOUGLAS WARNER III SEE SCHEDULE O 4.0 0.0 X 0 0 0 DEBORAH C WRIGHT SEE SCHEDULE O 2.0 0.0 X 0 0 0 SIMON NICHOLAS POWELL MD SEE SCHEDULE O 50.0 0.0 X 1566822 0 68721 CRAIG B THOMPSON MD SEE SCHEDULE O 50.0 0.0 X X 2345300 0 228785 JOSE BASELGA MD SEE SCHEDULE O 50.0 0.0 X X 947172 0 76741 WILLIAM E FORD SEE SCHEDULE O 2.0 0.0 X 0 0 0 JAMIE C NICHOLLS SEE SCHEDULE O 2.0 0.0 X 0 0 0 MARTHA VIETOR GLASS SEE SCHEDULE O 2.0 0.0 X 0 0 0 ERIC M COTTINGTON SEE SCHEDULE O 50.0 0.0 X 717685 0 76448 THOMAS KELLY MD SEE SCHEDULE O 50.0 0.0 X 1292578 0 87916 JASON KLEIN SEE SCHEDULE O 50.0 0.0 X 1259272 0 577620 EDWARD MAHONEY SEE SCHEDULE O 50.0 0.0 X 750267 0 65122 KATHRYN MARTIN SEE SCHEDULE O 50.0 0.0 X 1462745 0 78243 ELLEN MILLER-SONET SEE SCHEDULE O 50.0 0.0 X 389401 0 53774 RICHARD K NAUM SEE SCHEDULE O 50.0 0.0 X 874880 0 68527 ROGER PARKER SEE SCHEDULE O 50.0 0.0 X 640572 0 49590 PATRICIA C SKARULIS SEE SCHEDULE O 50.0 0.0 X 894948 0 51413 CAROLYN B LEVINE SEE SCHEDULE O 50.0 0.0 X 394037 0 41017 KERRY BESSEY SEE SCHEDULE O 50.0 0.0 X 630079 0 76591 AVICE MEEHAN SEE SCHEDULE O 50.0 0.0 X 503959 0 45296 EDWIN TALIAFERRO SEE SCHEDULE O 50.0 0.0 X 250399 0 51855 MURRAY BRENNAN MD SEE SCHEDULE O 50.0 0.0 X 966732 0 88577 MAUREEN KILLACKEY SEE SCHEDULE O 50.0 0.0 X 583276 0 49098 KENNETH MARIANS SEE SCHEDULE O 50.0 0.0 X 572179 0 74201 LARRY NORTON MD SEE SCHEDULE O 50.0 0.0 X 728699 0 59623 GEORGE BOSL MD SEE SCHEDULE O 50.0 0.0 X 1008488 0 72856 HEDVIG HRICAK MD SEE SCHEDULE O 50.0 0.0 X 1405067 0 71867 ANNE MCSWEENEY SEE SCHEDULE O 50.0 0.0 X 710433 0 69438 PETER T SCARDINO MD SEE SCHEDULE O 50.0 0.0 X 1937270 0 75090 RICHARD BARAKAT MD SEE SCHEDULE O 50.0 0.0 X 929048 0 66521 PAUL SABBATINI MD SEE SCHEDULE O 50.0 0.0 X 576853 0 40571 MICHELLE BURKE SEE SCHEDULE O 50.0 0.0 X 342845 0 36517 ELIZABETH MC CORMICK SEE SCHEDULE O 50.0 0.0 X 500160 0 48331 CYNTHIA MC COLLUM SEE SCHEDULE O 50.0 0.0 X 496623 0 60121 MARGARET BURKE SEE SCHEDULE O 50.0 0.0 X 546814 0 64966 WENDY PERCHICK SEE SCHEDULE O 50.0 0.0 X 568852 0 49204 CHARLES LUCARELLI DIRECTOR PHARMACY 50.0 0.0 X 298793 0 55832 JEFFREY HENSLEY ASSOC. HOSPITAL ADMINISTRATOR 50.0 0.0 X 367002 0 49420 JATIN SHAH MD SEE SCHEDULE O 50.0 0.0 X 2902593 0 78127 PETER G CORDEIRO MD SEE SCHEDULE O 50.0 0.0 X 1351778 0 68732 PHILIP GUTIN MD SEE SCHEDULE O 50.0 0.0 X 2596958 0 52711 JOSEPH DISA MD SEE SCHEDULE O 50.0 0.0 X 1287797 0 68588 MARK BILSKY MD SEE SCHEDULE O 50.0 0.0 X 1754182 0 363757 KATHY LEWIS EPSTEIN SEE SCHEDULE O 0.0 0.0 X 143610 0 5022 ROBERT WITTES MD SEE SCHEDULE O 0.0 0.0 X 128179 0 11413 41498575 0 3619848 3522 true true false TURNER CONSTRUCTION 375 HUDSON STREET NEW YORK NY 10014 GENERAL CONSTRUCT. 61247170 JGN CONSTRUCTION CORP 66-40 69TH STREET MIDDLE VILLAGE NY 11379 GENERAL CONSTRUCT. 16590115 PERKINS EASTMAN ARCHITECTS 115 FIFTH AVENUE NEW YORK NY 10003 ARCHITECTURAL 25851686 HUNTER ROBERTS CONSTRUCTION GR LLC 2 WORLD FINANCIAL CENTER NEW YORK NY 10001 GENERAL CONSTRUCT. 40718501 MICHAEL ANTHONY CONTRACTING 161 RAILROAD AVENUE GARDEN CITY NY 11040 GENERAL CONSTRUCT. 4335868 155 638038 150656000 386863892 5801714 538157930 MEDICAL CARE 622310 2377063000 2377063000 NON-GOVERNMENT SPONSORED RESEARCH 541711 41560000 41560000 2418623000 37238000 -2579730 39817730 9624000 9624000 94058000 94058000 0 0 0 715399094 151418000 538660094 89223000 176739000 62195000 238934000 238934000 2843070 638038 856128 1986942 1986942 0 0 PARKING & STAFF HOUSING 722212 33461000 33461000 CAFETERIA 722212 4192000 4192000 VENDOR DISCOUNTS 561439 971000 971000 8846000 8846000 47470000 3386091872 2418623000 -2579730 431890672 1000000 1000000 55370000 55370000 0 0 33964061 29610043 2549205 1804813 296463 296463 1199851706 1181048140 3820287 14983279 123756891 122100931 660311 995649 207486025 194600854 9533232 3351939 73281253 71657550 646050 977653 0 9462547 7425946 1455634 580967 1119634 954146 122564 42924 526688 526688 1346005 1346005 8773956 8773956 46724337 41766675 4057433 900229 9347637 334769 6102693 2910175 203679493 179155751 3388995 21134747 14400296 14269564 50981 79751 8270422 8270422 95299902 88442718 5839580 1017604 9417091 8584430 271884 560777 0 11789482 10668631 300231 820620 55038722 54722141 316581 0 210373358 205403745 4292601 677012 14428672 16650218 -2239154 17608 PHARMACEUTICALS 348220457 348220457 MEDICAL/SURGICAL SUPPLIES 154415031 154415031 PROVISION BAD DEBT-REG ASSMT 19964870 19881087 83783 UBIT EXPENSE 197001 197001 -856128 7364022 -7632270 -587880 2916945872 2814470000 50862000 51613872 X 20986529 10462691 10523838 241948000 213478000 255285000 366501000 434056000 574243000 403223000 411312000 300000 200000 0 0 30194000 29429000 34976000 39450000 96161000 99967000 4200039000 1971740000 2221313000 2228299000 3287213000 3685090000 788950000 830153000 1989000 3296000 0 0 0 0 7795608000 8481418000 483925000 503569000 0 0 0 0 1308088000 1252891000 0 0 0 0 0 0 845140000 845140000 925403000 735844000 3562556000 3337444000 X 3274857000 3932443000 500568000 656237000 457627000 555294000 4233052000 5143974000 7795608000 8481418000 X 469146000 269151000 172625000 X false true X true true true X X false false false SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 131624182 04 true true true 0 MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASES 131624082 03 true true true 0 LOUIS V GERSTNER JR GRADUATE SCHOOL OF BIOMEDICAL SCIENCE 202212588 02 true true true 0 3 0 5000 299661000 465007000 388184750 538157930 1691015680 0 0 5000 299661000 465007000 388184750 538157930 1691015680 0 1691015680 90061649 105245644 120044350 128632692 143499730 587484065 0 37155110 38398000 45187000 46748250 50313070 217801430 2496301175 10465418000 0.67741 0.00000 X SUPPORTED ORGANIZATIONS SUPPORT FROM MEMORIAL SLOAN-KETTERING CANCER CENTER AND S.K.I. REALTY, INC. RELATE PRINCIPALLY TO THE SHARING OF CERTAIN FACILITIES, EQUIPMENT, PERSONNEL COSTS, REQUISITION SERVICES (WHICH MAY INCLUDE SERVICES SUCH AS CONFRENCE PLANNING, MOTION MEDIA, MEDICAL GRAPHICS AND FACILITIES MANAGEMENT) AND ALLOCATIONS. AMOUNTS DUE TO OR DUE FROM AFFILIATES RESULTING FROM THESE SERVICES DO NOT BEAR INTEREST. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false true false false false false true 236402 false true 290286 526688 false FORM 990, SCHEDULE C, PART II-B MSKCC ENGAGES IN BOTH FEDERAL AND STATE LOBBYING. THE CENTER'S FEDERAL LOBBYING EFFORT FOCUSES ON PATIENT CARE AND REIMBURSEMENT ISSUES. PATIENT CARE ADVOCACY INCLUDES ENSURING PATIENTS ARE ABLE TO ACCESS CLINICAL TRIALS AND CANCER HOSPITALS ARE ABLE TO EFFECTIVELY RESEARCH POTENTIAL TREATMENTS FOR CANCER AS WELL AS PREVENTIVE AND PALLIATIVE MEASURES. THE CENTER ALSO SEEKS TO RECEIVE EQUITABLE REIMBURSEMENT FOR SERVICES RENDERED TO PATIENTS ENROLLED IN ENTITLEMENT PROGRAMS. FROM TIME TO TIME THE CENTER WEIGHS IN ON OTHER FEDERAL LEGISLATION THAT IMPACTS CANCER CARE AND HOSPITALS IN GENERAL. THE CENTER'S STATE LOBBYING EFFORT CONCENTRATES ON LEGISLATION THAT IMPACTS PROVIDERS' ABILITIES TO EFFECTIVELY CARE FOR PATIENTS, SUCH AS LEGISLATION THAT AMENDS CONSTRUCTION REVIEW PROCEDURES, PROVIDES FUNDING FOR BLOOD DONATION DRIVES, OR ENCOURAGES COLLABORATION BETWEEN CARE PROVIDERS AT HOSPITAL FACILITIES. STATE EFFORTS ALSO FOCUS ON ADVOCATING FOR HEALTH CARE ISSUES DURING STATE BUDGET NEGOTIATIONS. LOCAL LOBBYING IS PERFORMED BY THE GREATER NEW YORK HOSPITAL ASSOCIATION ON BEHALF OF ITS MEMBERS. PART II-B LINE 1I OTHER ACTIVIES LOBBYING PORTION OF DUES PAID: AMERICAN HOSPITAL ASSOCIATION $ 29,675 GREATER NEW YORK HOSPITAL ASSOCIATION $208,511 ADMINISTRATIVE COST AND RETAINER FEES: CAMMARANO, LAYTON & BOMBARDIERS $ 26,850 MURTHA CULLINA $ 25,250 false false 709754000 56687000 44303000 57495000 753249000 726867000 24401000 10195000 51709000 709754000 748997000 32670524 -2933000 51867524 726867000 767701000 13421000 9453000 41578000 748997000 776235000 5531000 23093000 37158000 767701000 0.26280 0.73720 false false 136470000 136470000 2925633000 1156912000 1768721000 86203000 55698000 30505000 1051733000 759130000 292603000 2228299000 85492000 C PRIVATE EQUITY & VENTURE CAP. 744661000 F 830153000 0 PENSION AND POSTRETIREMENT 380631000 INSURANCE RESERVES 231382000 DEFERRED COMPENSATION 53966000 ASSET RETIREMENT OBLIGATIONS 33426000 DEFERRED GIFT ANNUITY 27167000 OTHER LIABILITIES 9272000 735844000 3638870000 269151000 856128 270007128 3368862872 17229000 17229000 3386091872 2899573000 856128 856128 2898716872 17229000 1000000 18229000 2916945872 SCHEDULE D PART V PERMANENT ENDOWMENT FUNDS ARE HELD BY THE ORGANIZATION IN PERPETUITY. INCOME EARNED ON THE FUND BALANCE IS USED TO SUPPORT THE OPERATIONS OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATED ORGANIZATIONS. PART XI LINE 2d OTHER $856,128 ARE DIRECT EXPENSES RELATING TO FUNDRAISING EVENTS. COSTS ARE REMOVED FROM THE STATEMENT OF FUNCTIONAL EXPENSES AND NETTED ON THE STATEMENT OF REVENUE. PART XII OTHER $856,128 ARE DIRECT EXPENSES RELATING TO FUNDRAISING EVENTS. COSTS ARE REMOVED FROM THE STATEMENT OF FUNCTIONAL EXPENSES AND NETTED ON THE STATEMENT OF REVENUE OFFSET BY A GRANT PAYMENT TO THE RALPH LAUREN CENTER FOR CANCER CARE AND PREVENTION FROM A RESERVED LIABILITY OF ($1,000,000). PART X LINE2 A FIN 48 FOOTNOTE DISCLOSURE, RELATING TO THE ACCOUNTING FOR INCOME TAXES, WAS NOT REQUIRED BECAUSE THERE WAS NO MATERIAL IMPACT ON THE INSTITUTION'S FINANCIAL STATEMENTS. true true true true true true true false false false false false false false false false false true SCHEDULE E, PART I THE SCHOOL'S NONDISCRIMINATORY POLICY IS PUBLICIZED ON ITS WEB SITE. HTTP://WWW.SLOANKETTERING.EDU/GERSTNER/HTML/54499.CFM ALL APPLICANTS TO THE LOUIS V. GERSTNER JR., GRADUATE SCHOOL OF BIOMEDICAL SCIENCES ARE CONSIDERED ON THE BASIS OF MERIT. THE SCHOOL DOES NOT DISCRIMINATE ON THE BASIS OF GENDER, RACE, COLOR, CREED, RELIGION, AGE, NATIONAL ORIGIN, DISABILITY, VETERAN STATUS, MARITAL STATUS, SEXUAL ORIENTATION, OR CITIZENSHIP STATUS IN ACCORDANCE WITH INSTITUTIONAL POLICY AND IN COMPLIANCE WITH THE REQUIREMENTS OF THE CIVIL RIGHTS ACT, THE EDUCATION ADMENDMENTS, THE REHABILITATION ACT, THE AGE DISCRIMINATION ACT, AND THE AMERICANS WITH DISABILITIES ACT. Central America and the Caribbean Investments 1003560148 Europe (Including Iceland and Greenland) Investments 75225044 1078785192 1078785192 true false true true true false SCHEDULE F, PART I, LINE 2 MEMORIAL SLOAN-KETTERING CANCER CENTER DOES NOT MAKE GRANTS OR USE GRANT MONEY OUTSIDE OF THE UNITED STATES. PART I LINE 3 VALUES SHOWN IN COLUMN F ARE THE MARKET VALUES FOR THE INVESTMENTS AT DECEMBER 31. X X X X X X X true TARGET MARKETEAM DIRECT MAIL CONSULTING false 7941876 480000 7461876 DONOR SERVICES TELEMARKETI CONSULTING false 8182868 494565 7688303 Paradysz Matera Co Mail list consulting false 3350869 202523 3148346 M R STRATEGIC SERVICES TELEMARKETI CONSULTING false 2794829 168917 2625912 22270442 1346005 20924437 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY SPRING BALL 1540514 314264 1226250 206021 84280 119998 FALL PARTY 530658 9508 521150 103170 6970 4 1409936 314266 1095670 62875 163095 5562 104157 3481108 638038 2843070 372066 163095 89842 231125 856128 1986942 true true X true X 500. true X 500. true true false true true 19114052 3170508 15943544 0.00550 90315120 29614762 60700358 0.02090 109429172 32785270 76643902 0.02640 15566905 470795 15096109 0.00520 146007484 9853227 136154257 0.04680 972386 7836 964550 0.00030 373558095 161114000 212444095 0.07310 1187106 105000 1082106 0.00040 537291975 171550858 365741117 0.12580 646721147 204336129 442385018 0.15220 299229 8408 290820 0.00010 298085 181000 117085 597314 189408 407905 0.00010 true 25358052 2109501 595798511 739511629 -143713118 X true true 2 1 MEMORIAL HOSP FOR CANCER & ALLIED DIS 1275 YORK AVENUE NEW YORK NY 10065 www.mskcc.org 7002020H X X X X A 2 MEMORIAL HOSP FOR CANCER & ALLIED DIS 136 MOUNTAIN VIEW BOULEVARD BASKING RIDGE NJ 07920 WWW.MSKCC.ORG 23478 EXTENSION CLINIC A A 2 true X X X X X X X X X 13 true false true X WWW.MSKCC.ORG X X X X X X X true false true true 500. true 500. true X X X X X X X true true X X X X true X true X X X false X X false false SUPPLEMENTAL INFORMATION FOR PART V, SECTION B. LINE 3 FROM JANUARY TO APRIL 2013, WE CONDUCTED AN ONLINE SURVEY OF COMMUNITY MEMBERS, PATIENTS, HEALTHCARE CONSUMERS AND CONSUMER ADVOCATES, NONPROFIT AND COMMUNITY-BASED ORGANIZATIONS, AND HEALTHCARE PROVIDERS TO GATHER PRIMARY INPUT ON THE NEED FOR CANCER CARE AND TREATMENT SERVICES IN THE COMMUNITY. WE RECEIVED NEARLY 1,500 COMPLETED SURVEY RESPONSES AS A RESULT OF OUR OUTREACH EFFORTS. MSK STAFF MEMBERS CONSISTENTLY COLLABORATE WITH A WIDE RANGE OF COMMUNITY CONTACTS IN ORDER TO BETTER UNDERSTAND THE BROAD INTERESTS AND HEALTH NEEDS OF THE COMMUNITY IDENTIFIED WITHIN OUR SERVICE AREA. WE REGULARLY CONSULT WITH REPRESENTATIVES FROM NUMEROUS ORGANIZATIONS, INCLUDING THE FOLLOWING: " AFYA FOUNDATION " AMERICAN CANCER SOCIETY " ARAB AMERICAN COMMUNITY TASK FORCE " THE BROOKLYN CENTER FOR HEALTH DISPARITIES, SUNY DOWNSTATE SCHOOL OF MEDICINE " CENTER TO REDUCE CANCER DISPARITIES, NATIONAL CANCER INSTITUTE " THE CITY COLLEGE OF NEW YORK " COMMUNITY HEALTH WORKER NETWORK OF NYC " GAY MEN'S HEALTH CRISIS " HEALTH LITERACY RESOURCE CENTER, LITERACY ASSISTANCE CENTER " LEUKEMIA & LYMPHOMA SOCIETY " MEXICAN CONSULATE COALITION " NEW YORK CITY C5 COLORECTAL CANCER INITIATIVE STEERING COMMITTEE " NEW YORK CITY DEPARTMENT OF EDUCATION " NEW YORK CITY DEPARTMENT OF HEALTH & MENTAL HYGIENE " NEW YORK IMMIGRATION COALITION " NEW YORK LANGUAGE ASSISTANCE WORKING GROUP " NEW YORK LAWYERS IN THE PUBLIC INTEREST " NEW YORK STATE DEPARTMENT OF HEALTH " NEW YORK STATE NATIONAL MINORITY HEALTH COUNCIL " QUEENS CANCER CENTER " RALPH LAUREN CENTER FOR CANCER CARE AND PREVENTION " SHINNECOCK RESERVATION " SOUTH ASIAN COUNCIL ON SOCIAL SERVICES " SOLVING KIDS CANCER INC. LINE 5D SUMMARY FINDINGS OF MSK'S CHNA WERE INCORPORATED INTO OUR ANNUAL COMMUNITY SERVICE PLAN REPORT. THE COMMUNITY SERVICE PLAN (CSP) IS MAILED TO LOCAL ELECTED OFFICIALS AND ORGANIZATIONS, AND IS PUBLICIZED THROUGH OUR COMMUNITY NEWSLETTER WHICH IS MAILED TO 60,000+ RESIDENTS OF MANHATTAN. THE CSP PROVIDES DIRECTION ON HOW TO ACCESS THE FULL NEEDS ASSESSMENT RESULTS ON OUR WEBSITE AND IS AVAILABLE TO THE PUBLIC AT WWW.MSKCC.ORG/COMMUNITYSERVICEPLANS. LINE 7 MSK'S NEEDS ASSESSMENT PROCESS IDENTIFIED TWO NEEDS THAT MSK IS LIMITED IN ITS ABILITY TO ADDRESS BECAUSE THESE CONCERNS ARE SUBJECT TO NEW YORK CITY MARKET CONDITIONS AND EXTERNAL AGENCY CONTROL. THEY ARE: " FACILITATE AFFORDABLE, PATIENT-FRIENDLY, AND CONVENIENT PUBLIC TRANSPORTATION TO OUR FACILITIES FROM SUBURBAN LOCATIONS AND THE OUTER BOROUGHS OF NYC " IDENTIFY ADDITIONAL AFFORDABLE HOUSING FOR PATIENTS AND THEIR FAMILIES NEAR OUR MAIN CAMPUS DURING TREATMENT TO ASSIST WITH TRANSPORTATION, MSK OPERATES SEVERAL JITNEYS TO TRANSPORT PATIENTS BETWEEN SITES AND NEGOTIATES REDUCED PARKING FEES AT GARAGES NEAR OUR SITES. OUR STAFF ALSO HELPS OUR PATIENTS TO COMPLETE A NEW YORK CITY ACCESS-A-RIDE PROGRAM APPLICATION FOR TRANSPORTATION ASSISTANCE FOR MEDICALLY ELIGIBLE PATIENTS. ELIGIBLE PATIENTS IN NEED ALSO HAVE ACCESS TO METRO CARDS TO COVER BUS AND SUBWAY FARE, PHILANTHROPIC FUNDS FOR TRANSPORTATION, AND REFERRALS TO COMMUNITY-BASED ORGANIZATIONS THAT OFFER FUNDS TOWARDS PATIENT OUT-OF-POCKET COSTS. MANY TRAVEL, PARKING, AND ACCOMMODATION RESOURCES ARE LISTED ON OUR WEBSITE AT WWW.MSKCC.ORG/CANCER-CARE/HOSPITAL-INFORMATION. LINE 12I IN ADDITION TO THE INCOME LEVEL AND ASSET LEVEL, WE ALSO CONSIDER THE TOTAL ROUTINE MONTHLY BILLS THAT A PATIENT/FAMILY HAS TO PAY IN CALCULATING AMOUNTS PATIENTS ARE BEING CHARGED. LINE 13 FOR MANY YEARS MSKCC HAS PROVIDED FINANCIAL HELP TO PATIENTS IN NEED. OUR FINANCIAL ASSISTANCE PROGRAM HELPS UNINSURED AND UNDERINSURED PATIENTS WITH HOUSEHOLD INCOME UP TO FIVE TIMES THE FEDERAL POVERTY LEVEL WHO CANNOT GET PUBLICLY FUNDED HEALTH INSURANCE OR CANNOT AFFORD TO PAY FOR THEIR MEDICAL CARE. PATIENTS ARE EDUCATED ABOUT THE FINANCIAL ASSISTANCE PROGRAM - ELIGIBILITY CRITERIA, THE APPLICATION PROCESS ETC. TO BE CONSIDERED FOR THE FINANCIAL ASSISTANCE PROGRAM, PATIENTS ARE ASKED TO PROVIDE CERTAIN PERTINENT DOCUMENTATION TO ASSIST IN DETERMINING THEIR ELIGIBILITY AND THE AMOUNT OF FINANCIAL ASSISTANCE THEY ARE QUALIFIED TO RECEIVE. TO FURTHER ENHANCE THE PROCESS, WE STRATEGICALLY PLACE FINANCIAL ASSISTANCE BROCHURES AT EACH REGISTRATION SITE AND AT THE FRONT DESK OF THE PATIENT FINANCIAL SERVICES OFFICE. WE INCLUDE COPIES WITH THE FIRST HOSPITAL BILL SENT TO PATIENTS AND WITH COLLECTION LETTERS MAILED OUT TO THEM. FURTHERMORE, THE FINANCIAL ASSISTANCE INFORMATION IS POSTED ON THE MSKCC WEBSITE AS WELL. LINE 16E MEMORIAL HOSPITAL REFERENCES THE FINANCIAL ASSISTANCE PROGRAM ON OUR HOSPITAL BILLS AND COLLECTION LETTERS. THOUGH WE DO NOT CALL EVERY PATIENT, WE DO ATTEMPT TO CALL PATIENTS WITH BALANCES ABOVE $25,000. IF A PATIENT CONTACTS US, WE DISCUSS DIFFERENT PAYMENT OPTIONS WITH THEM SUCH AS TIME PAYMENTS, SETTLEMENTS AND THE FINANCIAL ASSISTANCE PROGRAM. IF A PATIENT IS REFERRED TO A COLLECTION AGENCY, THE COLLECTION AGENCY WILL MAKE MULTIPLE COLLECTIONS EFFORTS BUT WILL NOT FILE LEGAL ACTION OR IMPACT A PATIENT'S CREDIT REPORT. IF A PATIENT APPLIES FOR FINANCIAL ASSISTANCE, THE COLLECTION AGENCY IS ADVISED TO STOP ALL COLLECTION EFFORTS. LINE 17E MEMORIAL HOSPITAL REFERENCES THE FINANCIAL ASSISTANCE PROGRAM ON OUR HOSPITAL BILLS AND COLLECTION LETTERS. THOUGH WE DO NOT CALL EVERY PATIENT, WE DO ATTEMPT TO CALL PATIENTS WITH BALANCES ABOVE $25,000. IF A PATIENT CONTACTS US, WE DISCUSS DIFFERENT PAYMENT OPTIONS WITH THEM SUCH AS TIME PAYMENTS, SETTLEMENTS AND THE FINANCIAL ASSISTANCE PROGRAM. IF A PATIENT IS REFERRED TO A COLLECTION AGENCY, THE COLLECTION AGENCY WILL MAKE MULTIPLE COLLECTIONS EFFORTS BUT WILL NOT FILE LEGAL ACTION OR IMPACT A PATIENT'S CREDIT REPORT. IF A PATIENT APPLIES FOR FINANCIAL ASSISTANCE, THE COLLECTION AGENCY IS ADVISED TO STOP ALL COLLECTION EFFORTS. LINE 18E EVERY HOSPITAL STATEMENT AND COLLECTION LETTER REFERENCES OUR FINANCIAL ASSISTANCE PROGRAM AND WHO TO CALL WHEN EXPERIENCING FINANCIAL DIFFICULTY. LINE 19D MSKCC does not have an emergency facility. ALL OF OUR PATIENTS REQUIRING URGENT CARE ARE ABLE TO RECEIVE IT REGARDLESS OF THEIR INSURANCE RESTRAINTS OR EVEN IF IT HAS NOT BEEN DETERMINED THAT THE PATIENT IS ELIGIBLE FOR MSKCC'S FINANCIAL ASSISTANCE PROGRAM. LINE 20D AN INDIVIDUAL WHO IS DETERMINED TO BE ELIGIBLE FOR FAP WILL NEVER BE CHARGED MORE FOR MEDICALLY NECESSARY CARE THAN THE AMOUNTS GENERALLY BILLED TO INDIVIDUALS WHO HAVE INSURANCE THAT COVERS 80 PERCENT OF THE TOTAL CHARGES. 14 LAURANCE S ROCKEFELLER OP PAVILION 160 EAST 53RD STREET NEW YORK NY 10065 EXTENSION CLINIC BREAST AND IMAGING CENTER 300 EAST 66TH STREET NEW YORK NY 10065 EXTENSION CLINIC MSKCC COMMACK 650 COMMACK ROAD COMMACK NY 11725 EXTENSION CLINIC MSKCC BASKING RIDGE-AMBULATORY CARE 136 MOUNTAIN VIEW BLVD BASKING RIDGE NJ 07920 EXTENSION CLINIC SIDNEY KIMMEL PROSTATE & UROLOGIC CENTER 353 EAST 68TH STREET NEW YORK NY 10065 EXTENSION CLINIC MSKCC SLEEPY HOLLOW 777 NORTH BROADWAY SLEEPY HOLLOW NY 10591 EXTENSION CLINIC MSKCC HAUPPAUGE 800 VETERANS MEMORIAL HIGHWAY HAUPPAUGE NY 11787 EXTENSION CLINIC MSKCC ATLANTIC AVENUE CENTER 557 ATLANTIC AVENUE BROOKLYN NY 11217 EXTENSION CLINIC MSKCC COUNSELING CENTER 641 LEXINGTON AVENUE NEW YORK NY 10065 EXTENSION CLINIC MSKCC OP IMAGING AT EAST 55 STREET 301 EAST 55TH STREET NEW YORK NY 10065 EXTENSION CLINIC POST TREATMENT RESOURCES PROGRAM 215 EAST 68TH STREET NEW YORK NY 10065 EXTENSION CLINIC THE BENDHEIM INTEGRATIVE MEDICINE CENTER 1429 FIRST AVENUE NEW YORK NY 10021 EXTENSION CLINIC THE HARLEM BREAST EXAMINATION CENTER 163 WEST 125TH STREET NEW YORK NY 10065 EXTENSION CLINIC MSKCC - 64TH STREET 205 EAST 64TH STREET NEW YORK NY 10065 EXTENSION CLINIC PART 1, LINE 3C A PATIENT WITH INCOME LESS THAN OR EQUAL TO 500% OF THE FPL IS ELIGIBLE FOR THE INSTITUTION'S FINANCIAL ASSISTANCE PROGRAM. FOR INSTANCE, THE INSTITUTION MAY REDUCE THE FEES INCURRED BY THE PATIENT OR ACCEPT AS FULL PAYMENT AMOUNTS PAID BY THE INSURANCE CARRIER ON THE PATIENT'S BEHALF. A PATIENT MAY ALSO QUALIFY FOR ASSISTANCE EVEN IF HIS/HER INCOME IS GREATER THAN THE THRESHOLD LIMIT. THIS IS BECAUSE THE INSTITUTION ADJUSTS PATIENTS' INCOME FOR ROUTINE MONTHLY EXPENSES, INCLUDING TAXES, TO DETERMINE DISPOSABLE INCOME. MSKCC ALSO DEDUCTS A SPECIFIC AMOUNT (DEBT BURDEN) AS A MONTHLY CLOTHES AND FOOD ALLOWANCE BASED ON A PATIENT'S FAMILY SIZE IN EVALUATING THE TYPE AND AMOUNT OF ASSISTANCE NEEDED. THE TABLES BELOW ILLUSTRATE THE 2013 INCOME GUIDELINES USED IN EVALUATING A PATIENT'S FINANCIAL STATUS. FAMILY ALLOWED RESOURCE FOOD & CLOTHING SIZE INCOME LEVELS ALLOWANCE 1 $57,450 $33,096 $1,147 2 $77,550 $40,734 $1,431 3 $97,650 $48,372 $1,641 4 $117,750 $56,012 $1,859 5 $137,850 $63,650 $2,062 6 $157,950 $71,288 $2,279 PART I, LINE 6A: EACH YEAR, THE INSTITUTION PUBLISHES AN ANNUAL REPORT, THE "COMMUNITY SERVICE PLAN", WHICH PROVIDES INFORMATION ON ITS PUBLIC HEALTH PROGRAMS AND FINANCIAL ASSISTANCE SERVICES. IT IS AVAILABLE ON OUR WEB SITE, WWW.MSKCC.ORG, AND BY MAIL UPON REQUEST. IT IS MAILED TO LOCAL ELECTED OFFICIALS AND ORGANIZATIONS AND IS PUBLICIZED THROUGH OUR COMMUNITY NEWSLETTER. PART I, LINE 7G: MEMORIAL SLOAN-KETTERING HAS CONSISTENTLY SET THE STANDARD OF CARE FOR PEOPLE WITH CANCER BY EMPHASIZING EARLY DETECTION, PRECISE DIAGNOSIS, AND INDIVIDUALLY TAILORED TREATMENT. THE HOSPITAL SUBSIDIZES CANCER SCREENING, TREATMENT, AND SUPPORT SERVICES TO FULFILL ITS MISSION AND TO HELP REDUCE CANCER HEALTH DISPARITIES AMONG MINORITY AND MEDICALLY UNDERSERVED POPULATIONS. MSKCC'S BREAST EXAMINATION CENTER OF HARLEM (BECH) PROVIDES BREAST AND CERVICAL CANCER SCREENING, COUNSELING AND PATIENT FOLLOW-UP, AS WELL AS EDUCATIONAL PROGRAMS TO UNINSURED PATIENTS THROUGHOUT THE NEW YORK CITY AREA. BECH HAS A DEDICATED STAFF, INCLUDING A HEALTH EDUCATOR WHOSE ROLE IS TO INITIATE AND IMPLEMENT OUTREACH ACTIVITIES IN HARLEM AND THE SURROUNDING COMMUNITIES. SINCE ITS INCEPTION IN 1979, BECH HAS HAD MORE THAN 233,370 VISITS, WITH 4,191 OF THOSE TAKING PLACE IN 2013. ALL SERVICES WERE PROVIDED AT NO OUT-OF-POCKET EXPENSE TO THE WOMEN WHO RECEIVED CANCER SCREENING AND FOLLOW-UP SERVICES. LOCATED IN HARLEM, THE RALPH LAUREN CENTER FOR CANCER CARE AND PREVENTION (RLCCCP) OFFERS CANCER SCREENING AND TREATMENT SERVICES TO ITS MEDICALLY UNDERSERVED COMMUNITY. THE RLCCCP, MADE POSSIBLE IN PART THROUGH A GIFT FROM THE POLO RALPH LAUREN CORPORATION, AND IS SUBSIDIZED, IN PART, BY A GRANT FROM MSKCC. SINCE ITS INCEPTION RLCCCP HAS CONDUCTED MORE THAN 105,000 VISITS, OF WHICH APPROXIMATELY 13,000 OCCURRED IN 2013. RLCCCP CONTINUES TO PROVIDE CARE TO INDIVIDUALS WHO PARTICIPATE IN MEDICAID AND MEDICAID MANAGED CARE PROGRAMS. TO BETTER SERVE THE NEEDS OF DIAGNOSED PATIENTS, THE RALPH LAUREN CENTER HAS EXPANDED ITS NAVIGATION EFFORTS BY CREATING A MULTIDISCIPLINARY TEAM FOR EACH ONCOLOGIST, CONSISTING OF A CLINICAL NURSE NAVIGATOR AND A LAY NAVIGATOR. BOTH NAVIGATORS ASSIST PATIENTS FROM THE TIME OF DIAGNOSIS TO COMPLETION OF TREATMENT AND BEYOND. THE CLINICAL NAVIGATOR FOCUSES ON MEDICAL ISSUES, WORKING WITH THE ONCOLOGIST TO ENSURE THAT THE PATIENT UNDERSTANDS THEIR DIAGNOSIS AND TREATMENT PLAN.THE LAY NAVIGATOR WORKS WITH THE PATIENT TO ELIMINATE BARRIERS, SUCH AS TRANSPORTATION, AND LINKING PATIENT SERVICES IN THE COMMUNITY AS DEEMED NECESSARY MEMORIAL SLOAN KETTERING'S PSYCHIATRY & BEHAVIORAL SERVICES DEPARTMENT OFFERS INPATIENT AND OUTPATIENT PSYCHOLOGICAL AND SOCIAL SUPPORT SERVICES TO PATIENTS, THEIR FAMILIES, AND CAREGIVERS. ALL MEDICAID OUTPATIENT VISITS AND INPATIENT ENCOUNTERS ARE SUBSIDIZED BY MEMORIAL SLOAN KETTERING, AS ARE UNREIMBURSED TIME AND EFFORT BY NURSES TO STAFF A SMOKING CESSATION CLINIC. APPROXIMATELY 700 PATIENTS WERE TREATED BY THE NURSING STAFF DURING 2013. PHILANTHROPIC FUNDS ARE USED TO SUPPORT A SIGNIFICANT NUMBER OF THE DEPARTMENT'S OVERALL CLINICAL AND TRAINING ACTIVITIES. THE INTEGRATIVE MEDICINE SERVICE PROVIDES FREE CLINICAL CARE FOR INPATIENTS. DURING 2013, THE SERVICE PROVIDED 8,756 TREATMENTS. THE CLINICAL SERVICES PROVIDED INCLUDE MUSIC THERAPY, TOUCH THERAPY, ACUPUNCTURE, YOGA, MEDITATION, GUIDED IMAGERY, AND DANCE THERAPY. A TOUCH THERAPY FOR CAREGIVERS COURSE IS OFFERED FREE OF CHARGE TO ANY INPATIENT AND THEIR FAMILY MEMBERS ONCE PER MONTH. PART I, LINE 7, COLUMN (F): THE AMOUNT OF THE BAD DEBT EXPENSE REMOVED FROM THE 2013 CALULATION IS $9,120,000. PART I, LINE 7: FINANCIAL ASSISTANCE REPRESENTS THE COST OF SERVICES PROVIDED TO PATIENTS WHO CANNOT AFFORD HEALTH CARE SERVICES DUE TO INADEQUATE RESOURCES AND/OR ARE UNINSURED OR UNDERINSURED. A PATIENT IS CLASSIFIED AS A FINANCIAL ASSISTANCE PATIENT IN ACCORDANCE WITH THE INSTITUTION'S ESTABLISHED POLICIES AND WHERE INSUFFICIENT PAYMENT FOR SUCH SERVICES IS ANTICIPATED. THE INSTITUTION CONSIDERS PATIENTS FOR FINANCIAL ASSISTANCE IF HOUSEHOLD INCOME IS LESS THAN 500% OF THE FEDERAL POVERTY GUIDELINES. SERVICES PROVIDED AS FINANCIAL ASSISTANCE ARE NOT REPORTED AS REVENUE. THE COSTS REPORTED IN THE TABLE WERE BASED ON VARIOUS SOURCES. FINANCIAL ASSISTANCE AND UNREIMBURSED MEDICAID AND MEDICARE COMMUNITY BENEFITS COST WERE BASED ON A COST TO CHARGE RATIO CALCULATION. THE TOTAL CHARGES ASSOCIATED WITH THESE PROGRAMS ARE MULTIPLIED BY A RATIO OF HISTORICAL EXPENSES TO CHARGES AS DERIVED FROM THE HOSPITAL'S NEW YORK STATE INSTITUTIONAL COST REPORT. THE COSTS ASSOCIATED WITH A PORTION OF THE HEALTH PROFESSIONAL EDUCATION COMMUNITY BENEFIT ARE ALSO OBTAINED FROM THE STEPDOWN OF COSTS PREPARED AS PART OF THE NYS INSTITUTIONAL COST REPORT. COSTS OF PROVIDING FINANCIAL ASSISTANCE AS CALCULATED PER THE ABOVE IS NET OF AMOUNTS RECEIVED FROM THE NYS BAD DEBT AND CHARITY CARE POOLS. TO ARRIVE AT THE AMOUNTS REPORTED ON THE TABLE ADDITIONAL STEPS AS OUTLINED BELOW WERE TAKEN. UNPAID COST OF GOVERNMENT SPONSORED HEALTH CARE REPRESENTS THE ESTIMATED DIFFERENCE BETWEEN THE PAYMENTS MADE UNDER THE MEDICARE AND MEDICAID PROGRAMS AND THE INSTITUTION'S COST OF PROVIDING THESE SERVICES AS CALCULATED ABOVE. THE INSTITUTION SUBTRACTS ALL REVENUES RECEIVED FROM THE MEDICARE AND MEDICAID PROGRAMS TO DETERMINE THE COMMUNITY BENEFIT PROVIDED. RESEARCH COMMUNITY BENEFIT COSTS REPRESENT ALL COSTS FOR BASIC TRANSLATIONAL AND CLINICAL RESEARCH SUPPORTED BY INSTITUTIONAL FUNDS, GOVERNMENTAL, AND OTHER NON-PROFIT ORGANIZATIONS. RESEARCH COSTS SUPPORTED BY INDIVIDUAL AND CORPORATE PHILANTHROPIC FUNDS, TOTALING $88,160,000 ARE NOT INCLUDED IN SCHEDULE H, PART I, LINE 7. THE INSTITUTION IS A PREEMINENT PROVIDER OF HEALTH TRAINING TO HEALTH PROFESSIONALS WHO DESIRE TRAINING IN THE SKILLS NECESSARY TO TREAT CANCER PATIENTS. THE INSTITUTION TRAINS PHYSICIANS, SCIENTISTS, MEDICAL STUDENTS, RADIOLOGY STUDENTS, NURSING STUDENTS, SOCIAL WORK STUDENTS AND INDIVIDUALS LOOKING TO CREATE A CAREER IN THE FIELD OF CANCER BIOLOGY. THE AMOUNTS REPORTED AS HEALTH TRAINING REPRESENTS INSTITUTIONAL FUNDS, AS WELL AS COSTS IN EXCESS OF AMOUNTS REIMBURSED BY THIRD PARTY PAYERS SUCH AS TRAINING GRANT REVENUES AND DIRECT MEDICAL EDUCATION PAYMENTS FROM THE MEDICARE PROGRAM. PART II: MSKCC ENGAGES IN AND SUPPORTS COALITION BUILDING ACTIVITIES THAT PROMOTE THE HEALTH OF THE COMMUNITIES THE INSTITUTION SERVES. STAFF MEMBERS ARE ENCOURAGED TO SHARE THEIR CLINICAL EXPERTISE AND EXPERIENCE WITH PARTNERING HEALTHCARE FACILITIES AND COMMUNITY ORGANIZATIONS. STAFF MEMBERS SERVE AND PARTICIPATE IN NUMEROUS COMMUNITY GROUPS INCLUDING THE AMERICAN CANCER SOCIETY, THE AMERICAN PUBLIC HEALTH ASSOCIATION, THE GREATER NEW YORK HOSPITAL ASSOCIATION, AND MANY HEALTH IMPROVEMENT ADVOCACY GROUPS FOR PARTICULAR TYPES OF CANCER. ALTHOUGH THE SIGNIFICANT COST OF STAFF TIME DEVOTED TO THESE ACTIVITIES IS NOT QUANTIFIED BY THE CENTER, THE INSTITUTION CONSIDERS THESE EFFORTS TO COLLABORATE AND BUILD COMMUNITY RESOURCES TO BE OF SIZEABLE COMMUNITY BENEFIT. PART III, LINE 2: THE AMOUNT SHOWN ON LINE 2 IS THE ACTUAL 2013 BAD DEBT WRITE-OFF WHICH IS DERIVED BY TAKING THE GROSS CHARGES ASSOCIATED WITH THE PROVISION FOR DEBTS AND MULTIPLYING BY A RATIO OF HISTORICAL EXPENSES TO CHARGES AS DERIVED FROM THE HOSPITAL'S NEW YORK STATE INSTITUTIONAL COST REPORT. A SEPARATE RATIO IS CALCULATED FOR EACH TYPE OF PATIENT CARE ACTIVITY: INPATIENT, OUTPATIENT AND PHYSICIAN. PART III, LINE 3: PATIENTS HAVE THE OPPORTUNITY TO PURSUE VARIOUS CHARITY CARE PROGRAMS THROUGH MSKCC'S FINANCIAL ASSISTANCE PROGRAM. IF A PATIENT IS FOUND TO HAVE THE APPROPRIATE RESOURCES TO PAY FOR HEALTH SERVICES AND DOES NOT, OR CHOOSES NOT TO PARTICIPATE IN AVAILABLE HEALTH BENEFIT PROGRAMS THE COLLECTION PROCESS WILL BE PURSUED IN ACCORDANCE WITH THE INSTITUTION'S POLICY. ONCE DEEMED UNCOLLECTABLE, THE CHARGES ARE CLASSIFIED AS BAD DEBTS AND ARE CHARGED OFF AS SUCH. THE AMOUNTS IN THE TABLE, RE true RALPH LAUREN CENTER FOR CANCER & PREVENTION 1919 MADISON AVENUE New York NY 10035 020597827 501(C)(3) 1000000 SUPPORT OPERATING COSTS 1 STIPENDS 2202 55370000 Description of Organization's Procedures for Monitoring the Use of Grants FOR THE YEAR 2013, THE AMOUNT IS FOR STIPENDS PAID TO 323 RESEARCH FELLOWS, 133 RESEARCH SCHOLARS, AND 55 GRADUATE SCHOOL STUDENTS. STIPENDS WERE ALSO PAID TO A TOTAL OF 1,691 CLINICAL INTERNS, RESIDENTS AND FELLOWS THAT FILLED 464 POSITIONS DURING THE YEAR. EDUCATION AND TRAINING INCLUDES CLASSROOM INSTRUCTION WITH HANDS-ON EXPERIENCE IN BOTH RESEARCH LABORATORIES AND CLINICAL CARE ACTIVITIES. THE AFOREMENTIONED GRANTEES ARE REQUIRED TO BE IN COMPLIANCE WITH ACADEMIC REQUIREMENTS. THIS INCLUDES DIRECT SUPERVISION AND DIRECTION BY PHYSICIANS AND RESEARCH INVESTIGATORS. RALPH LAUREN CENTER FOR CANCER CARE & PREVENTION DURING 2013, MSKCC PAID $1,000,000 TO THE RALPH LAUREN CENTER FOR CANCER CARE & PREVENTION TO OFFSET OPERATING EXPENSES. THIS AMOUNT PAID WAS FROM A PREVIOUSLY ACCRUED LIABILITY. THE BOARD HAD APPROVED RESOLUTIONS TO SUPPORT THE RALPH LAUREN CENTER'S LOSSES UP TO $3,300,000 CUMULATIVELY SINCE 2011. MSKCC REGULARY MEETS WITH THE RALPH LAUREN CENTER'S BOARD OF DIRECTORS TO REVIEW THAT THEIR SPENDING IS IN CONFORMITY WITH THEIR MISSION. X X true true X X X X X false true false false false false false false true true JOHN R GUNN SEE SCHEDULE O 1023992 0 584319 0 69220 0 39900 0 39915 0 1757346 0 20000 0 MICHAEL P GUTNICK SEE SCHEDULE O 858870 0 573418 0 47300 0 39900 0 46546 0 1566034 0 20000 0 MARK SVENNINGSON SEE SCHEDULE O 526765 0 107200 0 83144 0 39900 0 35445 0 792454 0 20000 0 ERIC M COTTINGTON SEE SCHEDULE O 444830 0 215270 0 57585 0 39900 0 36548 0 794133 0 18054 0 MURRAY BRENNAN MD SEE SCHEDULE O 913222 0 0 0 53510 0 27674 0 60903 0 1055309 0 10000 0 THOMAS KELLY MD SEE SCHEDULE O 858416 0 414162 0 20000 0 40090 0 47826 0 1380494 0 20000 0 MAUREEN KILLACKEY SEE SCHEDULE O 558079 0 0 0 25197 0 26071 0 23027 0 632374 0 20000 0 JASON KLEIN SEE SCHEDULE O 729109 0 500000 0 30163 0 539900 0 37720 0 1836892 0 20000 0 KATHY LEWIS EPSTEIN SEE SCHEDULE O 47346 0 90948 0 5316 0 3810 0 1212 0 148632 0 5316 0 EDWARD MAHONEY SEE SCHEDULE O 487707 0 231750 0 30810 0 39900 0 25222 0 815389 0 20000 0 KENNETH MARIANS SEE SCHEDULE O 486643 0 60000 0 25536 0 39900 0 34301 0 646380 0 20000 0 KATHRYN MARTIN SEE SCHEDULE O 833355 0 557189 0 72201 0 39900 0 38343 0 1540988 0 20000 0 ELLEN MILLER-SONET SEE SCHEDULE O 285036 0 80041 0 24324 0 18226 0 35548 0 443175 0 1680 0 RICHARD K NAUM SEE SCHEDULE O 403334 0 444825 0 26721 0 36087 0 32440 0 943407 0 13965 0 LARRY NORTON MD SEE SCHEDULE O 591179 0 115054 0 22466 0 29483 0 30140 0 788322 0 10000 0 ROGER PARKER SEE SCHEDULE O 423933 0 190176 0 26463 0 37440 0 12150 0 690162 0 13035 0 PATRICIA C SKARULIS SEE SCHEDULE O 592508 0 282440 0 20000 0 39900 0 11513 0 946361 0 20000 0 ROBERT WITTES MD SEE SCHEDULE O 128179 0 0 0 0 0 10273 0 1140 0 139592 0 0 0 GEORGE BOSL MD SEE SCHEDULE O 943969 0 25000 0 39519 0 39900 0 32956 0 1081344 0 20000 0 HEDVIG HRICAK MD SEE SCHEDULE O 1257364 0 0 0 147703 0 27722 0 44145 0 1476934 0 10000 0 ANNE MCSWEENEY SEE SCHEDULE O 432167 0 254434 0 23832 0 29701 0 39737 0 779871 0 8703 0 SIMON NICHOLAS POWELL MD SEE SCHEDULE O 1395422 0 0 0 171400 0 27602 0 41119 0 1635543 0 10000 0 PETER T SCARDINO MD SEE SCHEDULE O 1397504 0 500000 0 39766 0 30150 0 44940 0 2012360 0 10000 0 JATIN SHAH MD SEE SCHEDULE O 1089816 0 0 0 1812777 0 22500 0 55627 0 2980720 0 1773670 0 PETER G CORDEIRO MD SEE SCHEDULE O 1291085 0 0 0 60693 0 30150 0 38582 0 1420510 0 10000 0 PHILIP GUTIN MD SEE SCHEDULE O 2557240 0 0 0 39718 0 22750 0 29961 0 2649669 0 10000 0 JOSEPH DISA MD SEE SCHEDULE O 1240694 0 0 0 47103 0 30150 0 38438 0 1356385 0 10000 0 CRAIG B THOMPSON MD SEE SCHEDULE O 1469856 0 840000 0 35444 0 39900 0 188885 0 2574085 0 20000 0 CAROLYN B LEVINE SEE SCHEDULE O 278884 0 61000 0 54153 0 21760 0 19257 0 435054 0 313 0 JOSE BASELGA MD SEE SCHEDULE O 897206 0 0 0 49966 0 39900 0 36841 0 1023913 0 0 0 KERRY BESSEY SEE SCHEDULE O 518971 0 100000 0 11108 0 39900 0 36691 0 706670 0 480 0 MARK BILSKY MD SEE SCHEDULE O 1694840 0 0 0 59342 0 330150 0 33607 0 2117939 0 10000 0 AVICE MEEHAN SEE SCHEDULE O 325242 0 75000 0 103717 0 24140 0 21156 0 549255 0 10000 0 EDWIN TALIAFERRO SEE SCHEDULE O 248833 0 0 0 1566 0 19309 0 32546 0 302254 0 0 0 RICHARD BARAKAT MD SEE SCHEDULE O 871554 0 0 0 57494 0 30150 0 36371 0 995569 0 0 0 PAUL SABBATINI MD SEE SCHEDULE O 459926 0 107500 0 9427 0 30150 0 10421 0 617424 0 12940 0 MICHELLE BURKE SEE SCHEDULE O 287290 0 50000 0 5555 0 23811 0 12706 0 379362 0 7804 0 ELIZABETH MC CORMICK SEE SCHEDULE O 385180 0 100000 0 14980 0 33790 0 14541 0 548491 0 2514 0 CYNTHIA MC COLLUM SEE SCHEDULE O 381643 0 100000 0 14980 0 33790 0 26331 0 556744 0 12230 0 MARGARET BURKE SEE SCHEDULE O 370438 0 125000 0 51376 0 32618 0 32348 0 611780 0 12230 0 WENDY PERCHICK SEE SCHEDULE O 387347 0 165030 0 16475 0 33979 0 15225 0 618056 0 9507 0 CHARLES LUCARELLI DIRECTOR PHARMACY 260428 0 35000 0 3365 0 21072 0 34760 0 354625 0 12230 0 JEFFREY HENSLEY ASSOC. HOSPITAL ADMINISTRATOR 288795 0 75000 0 3207 0 24444 0 24976 0 416422 0 569 0 Supplemental Compensation Information SCHEDULE J, PART I, LINE 1A BUSINESS OR FIRST CLASS TRAVEL IS GENERALLY NOT ALLOWED FOR FLIGHTS LESS THAN 6 CONTINUOUS HOURS. ALL TRAVEL MUST BE APPROVED BEFORE ANY ARRANGEMENTS ARE MADE. THE DUTIES TO BE PERFORMED BY OUR PRESIDENT REQUIRE HIM TO BE ON CALL AND TO PERFORM DUTIES AS AND WHEN APPROPRIATE DURING HIS OFF-DUTY PERIODS AS WELL AS DURING NORMAL OFFICE HOURS. AN EMPLOYMENT CONTRACT REQUIRES OUR PRESIDENT TO LIVE IN THE OFFICIAL RESIDENCE OWNED AND MAINTAINED BY THE INSTITUTION. THE CONTRACT REQUIRES OUR PRESIDENT TO USE THE RESIDENCE FOR INSTITUTIONAL PURPOSES, INCLUDING, BUT NOT LIMITED TO, MEETINGS WITH AND ENTERTAINMENT OF STAFF, DONORS AND POTENTIAL DONORS, VISITING PROFESSORS AND SCIENTISTS, AND OTHER PERSONS INVOLVED WITH THE AFFAIRS OF THE INSTITUTION, CONFIDENTIAL INTERVIEWS WITH MEMBERS AND PROSPECTIVE MEMBERS OF THE STAFF; AND FOR OTHER INSTITUTIONAL ACTIVITIES CONDUCTED DURING AND OUTSIDE OF NORMAL OFFICE HOURS. THE BENEFIT IS TREATED IN ACCORDANCE WITH CODE SECTION 119. SCHEDULE J,PART I, LINE 4B THE INSTITUTION MAINTAINS A NONQUALIFIED DEFERRED COMPENSATION PLAN WHICH IS USED FOR EMPLOYER CONTRIBUTIONS IN EXCESS OF THOSE ALLOWED BY THE RETIREMENT PLAN. DR. SHAH RECEIVED $1,763,670 DISTRIBUTION FROM THE NONQUALIFIED DEFERRED COMPENSATION PLAN AND $10,000 OF EXCESS 403B BENEFITS THAT WERE REPORTED AS COMPENSATION IN A PRIOR YEAR AND ARE TAXABLE IN THE CURRENT YEAR. PART I LINE 8 AN EMPLOYMENT CONTRACT WAS ENTERED INTO AND SIGNED PRIOR TO EMPLOYMENT. SCHEDULE J, PART III GRANDFATHERED MSKCC DEFERRED COMPENSATION PLANS Included in Other Reportable Compensation are certain distributions from deferred compensation plans that the Institution maintains for certain management and HIGHLY COMPENSATED employees. These grandfathered plans were adopted in the early and mid-1980s and have been closed to new participants since August 16, 1986. The grandfathered plans allowed participants to irrevocably defer portions of their approved salary until certain conditions were met, typically retirement or disability. In addition, the Institution made contributions to the plans to the extent contributions to the MSKCC Retirement Plan for such participants were limited by applicable contribution limits under the Internal Revenue Code. The Institution provided participants with the opportunity to receive distributions as permitted under Section 409A of the Internal Revenue Code. This opportunity was exercised by numerous participants. These distributed amounts are reported as W-2 compensation. 100 percent of these amounts reflect the deferral of a portion of the participant's approved compensation package and related investment experience since the commencement of an individual's plan participation. As contributions were made to these plans for previous periods, the contribution amounts were reported on Form 990 for the applicable period as contributions to deferred compensation plans with respect to officers, key employees, and other highest paid employees. These amounts, as adjusted for investment experience, are reported again now on Form 990 as distributions from the plans. A DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 64983QS83 2006-06-29 102783274 SEE PART VI false false false B DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 64983QT25 2006-06-29 114610323 SEE PART VI false false false C DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 649903B91 2008-05-13 456109226 SEE PART VI false false false D DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 2009-08-13 75000000 SEE PART VI false false false A 0 0 112974138 0 0 0 1525106 0 0 111449032 0 0 2009 false false true true B 0 0 123916313 0 0 77993404 1762909 0 0 0 44160000 0 false true true true C 0 0 456110736 0 0 0 6109226 0 0 0 450001510 0 true false true true D 63363371 0 75002371 0 0 0 0 0 0 75002371 0 0 false false true true A false false false true false 0.00000 0.00000 0.00000 false false false true B false false false true false 0.00000 0.00000 0.00000 false false false true C 0.00000 0.00000 0.00000 D false false false true false 0.00000 0.00000 0.00000 false false false true A false true false false false false 0 false 0 false true B false true false false false false 0 false 0 false true C false false false true false false 0 false 0 false true D false true false false false false 0 false 0 false true A true B true C true D true 1 PART I COL (F) DESCRIPTION OF PURPOSE 2006 SERIES I BONDS CUSIP #64983QS83: 2006 SERIES I BONDS WERE USED TO FINANCE OR REFINANCE ALL OR A PORTION OF THE COST OF THE FOLLOWING: BEGAN CONSTRUCTION ON A NEW EIGHT-STORY RESEARCH FACILITY, COMPLETED THE 23 STORY RESEARCH FACILITY, PURCHASED 96 RESIDENTIAL CONDOMINIUM APARTMENTS FOR STAFF OF THE INSTITUTION, IMPROVE A 13-STORY RESEARCH FACILITY. 2006 SERIES II BONDS CUSIP #64983QT25: 2006 SERIES II BONDS WERE USED TO ADVANCE REFUND A PORTION OF THE 2003 BONDS ISSUED ON MAY 14, 2003. 2008 SERIES I BONDS CUSIP #649903B91: 2008 SERIES BONDS WERE USED TO ADVANCE REFUND A PORTION OF THE 2002A BONDS ISSUED IN JANUARY 24, 2002 2009 TAX EXEMPT LEASING PROGRAM (TELP) 2009 TELP WAS USED TO LEASE FINANCE MEDICAL AND RESEARCH LABORATORY EQUIPMENT 2012 SERIES BONDS CUSIP 649906RK2: A PORTION OF THE PROCEEDS FROM THE SALE OF THE SERIES 2012 BONDS, TOGETHER WITH OTHER AVAILABLE FUNDS, IS EXPECTED TO BE USED TO FINANCE ALL OR A PORTION OF THE COST OF CONSTRUCTING, IMPROVING AND EQUIPPING A NEW AMBULATORY CARE FACILITY IN HARRISON, NEW YORK. THE REMAINDER OF THE BOND PROCEEDS WERE USED TO ADVANCE REFUND THE 2003 BONDS ISSUED ON MAY 14, 2003. 2013 SERIES I BONDS CUSIP #6499053Z7: 2013 SERIES BONDS ARE EXPECTED TO BE USED TO FINANCE ALL OR A PORTION OF THE COST OF CONSTRUCTING AND EQUIPPING A NEW AMBULATORY CARE FACILITY IN MANHATTAN, NEW YORK. PART II LINE 3: TOTAL AMOUNT OF PROCEEDS THE AMOUNT OF PROCEEDS ON PART II LINE 3 IS DIFFERENT FROM PART I COLUMN (E) BECAUSE PART II LINE 3 INCLUDES INVESTMENT INCOME. PART III, LINE 3 (D) ANY RESEARCH AGREEMENTS THAT MAY RESULT IN PRIVATE BUSINESS USE OF BOND FINANCED PROPERTIES ARE REVIEWED FIRST BY IN-HOUSE STAFF WHO ARE KNOWLEDGEABLE AND RESPONSIBLE FOR THE FORM 990. OUTSIDE COUNSEL IS CONSULTED IF QUESTIONS ARISE. PART IV, LINE 2 (C ) ARBITRAGE THE REBATE COMPUTATION ON THE 2008 BOND ISSUES WERE PERFORMED IN MAY 2013. A DORMITORY AUTHORITY OF THE STATE OF NEW YORY 146000293 649906RK2 2012-02-16 388814944 SEE PART VI false false false B DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 6499063Z7 2013-06-28 80000000 SEE PART VI false false false A 0 0 389666707 0 7803422 0 2651698 0 0 49935855 288922724 40353008 false true false true B 2000000 0 80323493 0 0 0 0 0 0 23838935 0 56484558 false false false true A false false false true 0.00000 0.00000 0.00000 false false false true B false 0 false false false true A false true false false false false 0 false 0 false true B false true false false false false 0 false 0 false true A true B true Hedvig Hricak MD CHAIR. DPT RADIOLOGY MORTGAGE X 700000 200000 false true true 200000 PERKINS EASTMAN SEE PART V 25851686 ARCHITECTUAL SERVICES false GENERAL ELECTRIC SEE PART V 11900924 SERVICE/PURCHASE OF EQUIPMENT false MERCK SEE PART V 4174890 PURCHASE OF PHARMACEUTICALS false Merck SEE PART V 1000015 ROYALTY false CHARLES RIVER LABORATORIES SEE PART V 951526 PURCHASE OF SUPPLIES false MS T LINDSTEN SEE PART V 187966 FAMILY EMPLOYMENT false MR I GUTNICK SEE PART V 79242 FAMILY EMPLOYMENT false IBM CORPORATION SEE PART V 2616483 SERVICE/PURCHASE OF EQUIPMENT false GENERAL ATLANTIC SEE PART V 831000 INVESTMENT MANAGEMENT FEES false KING STREET CAPITAL MANAGEMENT SEE PART V 645000 INVESTMENT MANAGEMENT FEES false JP MORGAN CHASE SEE PART V 934583 BANK FEES false MR L SELBY SEE PART V 29255 FAMILY EMPLOYMENT false FORM 990, SCHEDULE L, PART IV 1. MR. STEPHEN FRIEDMAN IS A BOARD MEMBER OF THE INSTITUTION. THE INSTITUTION PURCHASED ARCHITECTURAL SERVICES FROM THE FIRM OF PERKINS/EASTMAN. THE TOTAL AMOUNT PAID IN 2013 WAS $25,851,686. MR. PERKINS AND MR. FRIEDMAN ARE BROTHERS-IN-LAW. 2. MR. DOUGLAS A. WARNER III IS CHAIRMAN OF THE BOARD OF THE INSTITUTION. MR. WARNER IS ALSO A DIRECTOR OF GENERAL ELECTRIC. DURING 2013 THE INSTITUTION PURCHASED MEDICAL EQUIPMENT AND SERVICES FROM G.E. IN THE AMOUNT OF $11,900,924. 3. DR. CRAIG THOMPSON IS PRESIDENT OF THE INSTITUTION, AND IS ON THE BOARD OF DIRECTORS OF MERCK AND HAS BEEN SINCE 2008. FROM TIME TO TIME, MEMORIAL SLOAN-KETTERING ENTERS INTO DIRECT CONTRACTS WITH MERCK. DURING 2013, THE VALUE OF THESE CONTRACTS APPROXIMATED $4,174,890. 4. DURING 2013 THE INSTITUTE RECEIVED $1,000,015 OF ROYALTIES FROM A LICENSE AGREEMENT WITH MERCK 5. IN DECEMBER 2013, DR. THOMPSON JOINED THE BOARD OF DIRECTORS AT CHARLES RIVER LABORATORIES. DURING 2013, MEMORIAL-SLOAN KETTERING MADE PURCHASES TOTALING $951,523. 6. DR. THOMPSON'S SPOUSE IS A LABORATORY MEMBER IN SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH. HER COMPENSATION FOR 2013 WAS $187,966. 7. MR. MICHAEL P. GUTNICK IS THE EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER. HIS SON IS A FUND COORDINATOR IN THE DIVISION OF MEDICINE. HIS SON'S TOTAL COMPENSATION FOR 2013 WAS $79,242. 8. MS. VIRGINIA M. ROMETTY IS A BOARD MEMBER OF THE INSTITUTION AND PRESIDENT AND CEO OF IBM. DURING 2013, THE INSTITUTION PURCHASED SERVICES AND EQUIPMENT FROM IBM TOTALING $2,616,483. Additionally, Memorial Sloan-Kettering Cancer Center, IBM and WellPoint have a unique agreement to develop a powerful cancer resource built upon the famous "IBM Watson" that will have the potential to advance the quality of oncology care for patients wherever they are treated.This joint project aims to build the world's most comprehensive, cancer-specific, evidence-based medical resource. MSK will share our clinical knowledge, research, and genomic and molecular data, along with continuously updated standards of care and other published data, to help populate the Watson system with the most-current cancer diagnostic and treatment information. Then, our physicians will "train" the IBM Watson system to evaluate and synthesize the vast stores of clinical information and the collective wisdom and knowledge of MSKCC's cancer experts. 9. MR. WILLIAM E. FORD IS A BOARD MEMBER OF THE INSTITUTION AND A PARTNER IN GENERAL ATLANTIC INVESTMENTS. DURING 2013, THE INSTITUTION PAID GENERAL ALANTIC $831,000 IN MANAGEMENT FEES. 10. MS. JAMIE NICHOLLS IS A BOARD MEMBER OF THE INSTITUTION. HER SPOUSE IS A CO-FOUNDER OF KING STREET CAPITAL MANAGEMENT. DURING 2013, THE INSTITUTION PAID KING STREET $645,000 IN MANAGEMENT FEES 11. MS. ELLEN FUTTER IS A BOARD MEMBER OF THE INSTITUTION AND A DIRECTOR OF JP MORGAN CHASE. DURING 2013, THE INSTITUTION PAID FEES TO JP MORGAN CHASE TOTALING $934,583. 12. MR. NORMAN C. SELBY IS A BOARD MEMBER WITHIN THE ORGANIZATION. HIS SON IS A RESEARCH FELLOW IN THE DEPARTMENT OF SURGERY. HIS SON'S TOTAL COMPENSATION FOR 2013 WAS $29,255. THE INDIVIDUALS LISTED WERE NOT A PARTY TO THE TRANSACTIONS. THERE IS NO SHARING OF THE INSTITUTION'S REVENUE. THE PURCHASES OF GOODS OR SERVICES BY THE INSTITUTION WERE MADE IN THE ORDINARY COURSE OF THE PROVIDER'S BUSINESS, AT COMMERCIALLY AVAILABLE RATES. X 1403571 THRIFT VALUE X 73 4398143 MARKET VALUE false true false LINE 9 EXCLUDED FROM THIS VALUE ARE PLEDGE PAYMENTS, MADE BY STOCK, TOTALING $15,145,274. PROMISES TO GIVE ARE REPORTED AT THE DATE THE INTENT IS MADE IN WRITING. LINE 32B CLOTHING AND HOUSEHOLD GOODS ARE DONATED AT OUR THRIFT SHOP. THE SOCIETY OF MSKCC RUNS THE THRIFT SHOP FOR THE BENEFIT OF THE ORGANIZATION. PUBLICLY TRADED DONATED STOCK IS SOLD BY MERRILL LYNCH ON BEHALF OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATED ORGANIZATIONS. FORM 990, PART VI, LINE 11B, PROCESS USED TO REVIEW THE RETURN PRIOR TO FILING THE RETURN, A REVIEW OF THE 990 WAS CONDUCTED BY THE CONTROLLER AND THE CHIEF FINANCIAL OFFICER. IT IS THEN REVIEWED BY THE JOINT AUDIT COMMITTEE OF THE BOARD. THE JOINT AUDIT COMMITTEE REFERS THE FORM 990 TO THE FULL BOARD, AND A COPY IS PROVIDED TO EACH BOARD MEMBER FOR FURTHER REVIEW. MEMORIAL SLOAN-KETTERING'S FORM 990 IS REVIEWED BY OUTSIDE COUNSEL AND IS PREPARED IN CONJUNCTION WITH ERNST AND YOUNG, LLP. FORM 990, PART VI, LINE 12C PROCESS USED TO MONITOR COMPLIANCE THE COMPLIANCE OFFICER AND STAFF ARE RESPONSIBLE FOR ADMINISTERING THE CONFLICT OF INTEREST PROGRAM--INCLUDING THE IMPLEMENTATION OF THE POLICY--BY MAINTAINING PROCESSES FOR DISCLOSURE OF OUTSIDE ACTIVITIES AND FOR THE TIMELY REVIEW OF REPORTED INTERESTS, INCLUDING: 1. MANAGEMENT OF THE ANNUAL DISCLOSURE CERTIFICATION PROCESS AND THE PROCESS BY WHICH COVERED PERSONS DISCLOSE AT TIME OF HIRE. COVERED PERSONS RECEIVE AN ANNUAL QUESTIONNAIRE REQUESTING DISCLOSURE OF RELATIONSHIPS AND TRANSACTIONS THAT MIGHT INVOLVE A CONFLICT OF INTEREST. QUESTIONNAIRE RESPONSES ARE REVIEWED BY THE COMPLIANCE OFFICER AND STAFF. FOLLOW-UP INQUIRIES ARE MADE IF NEEDED. MATTERS ARE SUBMITTED TO AN INTERNAL MANAGEMENT COMMITTEE AND A COMMITTEE OF THE BOARD OF MANAGERS IF ADJUDICATION IS NEEDED. 2. REVIEW AND ADJUDICATION OF OUTSIDE ACTIVITIES THAT REQUIRE PRE- APPROVAL OR DISCLOSURE; FACILITATION OF A REVIEW BY THE OFFICE OF INDUSTRIAL AFFAIRS OF ANY OUTSIDE ACTIVITIES THAT INVOLVE INTELLECTUAL PROPERTY OR OTHERWISE INVOLVE AN ACTIVITY IN WHICH THE CENTER'S RIGHTS MAY REQUIRE PROTECTION. 3. ADMINISTRATION OF CONFLICT OF INTEREST ADVISORY COMMITTEE MEETINGS, INCLUDING DEVELOPMENT AND DISTRIBUTION OF AGENDAS AND SUPPORTING DOCUMENTS, DRAFTING AND DISTRIBUTION OF MINUTES, AND MAINTENANCE OF COMMITTEE RECORDS. 4. DOCUMENTATION OF THE OUTCOME OF ALL REVIEWS OF REPORTED OUTSIDE ACTIVITIES. COMMUNICATION TO THE COVERED PERSON OF THE OUTCOME OF ALL REVIEWS, INCLUDING DOCUMENTATION OF MANAGEMENT PLANS. AS PART OF THE CLINICAL RESEARCH REVIEW PROCESS, QUESTIONS ON THE PROTOCOL SUBMISSION FORM ARE DESIGNED TO ELICIT INFORMATION ABOUT POTENTIAL CONFLICTS. SITUATIONS IN WHICH A STAFF PARTICIPANT IN RESEARCH REPORTS A POTENTIAL CONFLICT ARE REFERRED TO THE CHAIR OF THE COIAC AND TO THE COMPLIANCE OFFICER FOR REVIEW. THE BOARD OF MEMORIAL SLOAN-KETTERING CANCER CENTER HAS MEMBERS THAT ACTIVELY SERVE AS OFFICERS AND/OR BOARD MEMBERS OF PUBLICLY-TRADED COMPANIES. THE INSTITUTION MAY PROCURE GOODS AND/OR SERVICES FROM THESE PUBLICLY TRADED COMPANIES THROUGH THE ORDINARY COURSE OF THE PROVIDER'S BUSINESS ON TERMS AND CONDITIONS WHICH ARE THE SAME THAT SUCH COMPANIES CHARGE TO THE GENERAL PUBLIC. ANY OF OUR BOARD MEMBERS THAT HAVE AN AFFILIATION WITH SUCH COMPANIES ARE NOT INVOLVED IN THE TRANSACTION, INCLUDING, WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, IN NEGOTIATING OR AFFECTING THE TERMS OF THE TRANSACTION. THE INSTITUTION HAS A COMPREHENSIVE CONFLICT OF INTEREST POLICY. TRANSACTIONS IDENTIFIED THROUGH OUR ANNUAL CONFLICT OF INTEREST QUESTIONNAIRE ARE DISCLOSED ON SCHEDULE L. THESE TRANSACTIONS WERE ALSO CONSUMMATED ON AN ARM'S LENGTH BASIS BY MANAGEMENT OF THE INSTITUTION. MSKCC'S "POLICY ON CONFLICTS OF INTERESTS FOR DIRECTORS AND KEY EMPLOYEES" APPLIES TO ANY BOARD OF MANAGERS MEMBER, PRINCIPAL OFFICER, OR MEMBER OF A COMMITTEE WITH BOARD-DELEGATED POWERS. INDIVIDUALS COVERED BY THIS POLICY HAVE A DUTY TO DISCLOSE FINANCIAL INTERESTS, AS DEFINED BY THE POLICY, ANNUALLY AND AS THEY ARISE. IN THE EVENT A COVERED INDIVIDUAL IS INVOLVED IN A BOARD OR COMMITTEE ACTION (SUCH AS APPROVAL OF A TRANSACTION OR ARRANGEMENT) AND THE INDIVIDUAL HAS A FINANCIAL INTEREST RELATED TO THE MATTER BEFORE THE BOARD, THE INDIVIDUAL MUST DISCLOSE THE FINANCIAL INTEREST AND ALL MATERIAL FACTS TO THE BOARD OR COMMITTEE. THE INDIVIDUAL MUST LEAVE THE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON, AND THE REMAINING, DISINTERESTED BOARD OR COMMITTEE MEMBERS ARE RESPONSIBLE TO DECIDE IF A CONFLICT EXISTS. IF A DETERMINATION IS MADE THAT A CONFLICT EXISTS, THE INVOLVED INDIVIDUAL MAY MAKE A PRESENTATION TO THE BOARD OR COMMITTEE BUT S/HE MUST LEAVE THE MEETING DURING THE DISCUSSION OF AND THE VOTE ON THE TRANSACTION OR ARRANGEMENT. THE BOARD OR COMMITTEE IS REQUIRED TO DETERMINE WHETHER MSKCC CAN OBTAIN A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT WITH REASONABLE EFFORTS FROM AN UNCONFLICTED PERSON OR ENTITY. AS APPROPRIATE, THE CHAIRPERSON OF THE BOARD OR COMMITTEE IS RESPONSIBLE TO APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. FORM 990, PART VI, LINE 15 PROCESS FOR DETERMINING COMPENSATION MEMORIAL SLOAN-KETTERING CANCER CENTER (MSKCC) IS COMMITTED TO ENSURING THAT ITS EXECUTIVE COMPENSATION PROGRAM ADHERES TO THE ESTABLISHED STANDARDS OF REGULATORY COMPLIANCE AND BEST CORPORATE GOVERNANCE. THE MSKCC BOARD OF OVERSEERS AND MANAGERS HAS CHARGED THE JOINT HUMAN RESOURCES COMMITTEE (WHICH IS COMPOSED ENTIRELY OF INDEPENDENT BOARD MEMBERS WITH NO CONFLICTS OF INTEREST IN REGARDS TO EXECUTIVE COMPENSATION) WITH MAKING ALL DECISIONS RELATED TO COMPENSATION FOR OFFICERS AND KEY EMPLOYEES. THE COMMITTEE REVIEWS THE TOTAL COMPENSATION OF THE INDIVIDUALS, INCLUDING BOTH CURRENT AND DEFERRED COMPENSATION, AND ALL EMPLOYEE BENEFITS, ON AN ANNUAL BASIS TO ENSURE THAT THE TOTAL COMPENSATION OF EACH OFFICER AND KEY EMPLOYEE IS REASONABLE. TO ASSIST IN THE COMPLETION OF ITS RESPONSIBILITIES, THE COMMITTEE ENGAGES THE SERVICES OF A NATIONALLY RECOGNIZED CONSULTING FIRM SPECIALIZING IN EXECUTIVE COMPENSATION FOR NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS. EACH YEAR THE COMMITTEE REVIEWS A COMPREHENSIVE REPORT PREPARED BY THE FIRM THAT INCLUDES MARKET DATA FOR FUNCTIONALLY COMPARABLE ROLES IN COMPARABLE ORGANIZATIONS (I.E., NOT-FOR-PROFIT ACADEMIC/RESEARCH MEDICAL CENTERS, ESPECIALLY THOSE SHARING A MISSION SIMILAR TO MSKCC, WITH OTHER HEALTHCARE SECTORS CONSIDERED ON A SELECTED BASIS) AND SUMMARIZES THE RELATIVE MARKET POSITION OF EACH EXECUTIVE'S TOTAL COMPENSATION. THE LAST REVIEW WAS DECEMBER 2013. THIS REVIEW SETS THE COMPENSATION POLICY FOR THE FOLLOWING YEAR. ADDITIONALLY, A SENIOR MEMBER OF THE CONSULTING FIRM ATTENDS THE COMMITTEE'S MEETINGS TO PROVIDE INFORMATION AND TO RESPOND TO QUESTIONS BY THE MEMBERS OF THE COMMITTEE. COMPENSATION LEVELS ARE ESTABLISHED CONSIDERING THE MARKET DATA, AN ASSESSMENT OF PERFORMANCE, AND OTHER BUSINESS JUDGMENT FACTORS, CONSISTENT WITH MSKCC'S EXECUTIVE COMPENSATION PHILOSOPHY. THE COMMITTEE'S DECISIONS ARE MADE IN THE BEST INTERESTS OF MSKCC, AND ARE INTENDED TO ENSURE THE RECRUITMENT AND RETENTION OF KEY EXECUTIVE TALENT, CONSISTENT WITH THE MARKET PRACTICES OF OTHER NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS OF COMPARABLE SCOPE, MISSION AND COMPLEXITY. ON AN ANNUAL BASIS, THE COMMITTEE PROVIDES THE FULL BOARD WITH AN OVERVIEW OF ITS DETERMINATIONS AND PROCESS. THE COMMITTEE'S REVIEW PROCESS FOLLOWS THE INTERMEDIATE SANCTIONS GUIDELINES FOR QUALIFYING FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE OF 1986: - THE COMPENSATION ARRANGEMENT IS APPROVED IN ADVANCE BY AN "AUTHORIZED BODY" OF THE APPLICABLE TAX EXEMPT ORGANIZATION (I.E, THE COMMITTEE, WHICH IS COMPOSED ENTIRELY OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITHIN THE MEANING OF THE REGULATIONS UNDER SECTION 4958). - THE AUTHORIZED BODY OBTAINS AND RELIES UPON "APPROPRIATE DATA AS TO COMPARABILITY" PRIOR TO MAKING ITS DETERMINATION, FOR WHICH COMPARABILITY DATA ARE PROVIDED AND ANALYZED BY SULLIVAN, COTTER AND ASSOCIATES, INC., A WELL-REGARDED EXPERT IN THE AREA OF HEALTHCARE COMPENSATION. - THE COMMITTEE ADEQUATELY DOCUMENTS THE BASIS FOR ITS DETERMINATION CONCURRENTLY WITH MAKING THAT DETERMINATION, AGAIN AS REQUIRED IN THE REGULATIONS. FORM 990, PART VI LINE 19 THE INSTITUTION MAKES ITS AUDITED FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. IN ADDITION, THE FINANCIAL STATEMENTS CAN BE ACCESSED AT THE FOLLOWING WEB ADDRESS: WWW.DACBOND.COM. THE INSTITUTION HAS ENGAGED DAC BOND AS OUR INVESTOR RELATIONS AND DISCLOSURE/DISSEMINATION AGENT. THE INFORMATION AVAILABLE ON THIS WEB SITE INCLUDES AUDITED FINANCIAL STATEMENTS, QUARTERLY UNAUDITED FINANCIAL STATEMENTS AND THE BOND OFFERING STATEMENTS FOR ALL OF OUR TAX-EXEMPT DEBT ISSUES. IN ADDITION, COPIES OF THE GROUP 990 AND FILED 990T ARE ALSO AVAILABLE. THE CONFLICT OF INTEREST POLICY IS AVAILABLE TO THE PUBLIC UPON REQUEST. IT CAN BE FOUND AT THE FOLLOWING INSTITUTIONAL WEB SITE: WWW.MSKCC.ORG. GOVERNING DOCUMENTS SUCH AS THE ARTICLES OF INCORPORATION AND CORPORATE BY-LAWS ARE NOT MADE AVAILABLE TO THE PUBLIC. FORM 990, PART VII, SECTION A THIS IRS FORM 990 IS FILED UNDER GROUP EXEMPTION NUMBER 3475, EIN 91-2154267. THE ATTACHED LIST REPRESENTS MEMBERS FROM THE GOVERNING BOARDS OF THE FOLLOWING AFFILIATED INSTITUTIONS THAT MAKE UP OUR EXEMPT GROUP: MEMORIAL SLOAN-KETTERING CANCER CENTER (MSK) EIN RALPH LAUREN CTR FOR CANCER & PREVENTION 1919 MADISON AVE NEW YORK NY 10036 CANCER CARE NY 501( C)3 9 MSKCC true MEM CRITICAL CARE 1275 YORK AVE NY NY 10065 133348785 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM INFECT DISEASE 1275 YORK AVE NY NY 10065 133278582 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM MEDICAL CONSULT 1275 YORK AVE NY NY 10065 133278550 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM NUTRITION GRP 1275 YORK AVE NY NY 10065 133278576 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM SOLID TUMOR GRP 1275 YORK AVE NY NY 10065 133278578 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PULMONARY FUNC 1275 YORK AVE NY NY 10065 133304834 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM CARDIOPULMONARY 1275 YORK AVE NY NY 10065 133278552 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK RADIOLOGY GRP 1275 YORK AVE NY NY 10065 133375559 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM NUCLEAR MED 1275 YORK AVE NY NY 10065 133278580 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM RADIATION ONCOL 1275 YORK AVE NY NY 10065 133237927 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PATHOLOGY GRP 1275 YORK AVE NY NY 10065 133365998 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM ANESTHESIOLOGY 1275 YORK AVE NY NY 10065 133367135 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PEDIATRICS GRP 1275 YORK AVE NY NY 10065 133346908 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM NEUROLOGY GRP 1275 YORK AVE NY NY 10065 133399377 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PSYCHIATRY GRP 1275 YORK AVE NY NY 10065 133430629 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK AT GUTTMAN 1275 YORK AVE NY NY 10065 133875002 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK PHYS AT PHELPS 1275 YORK AVE NY NY 10065 133897156 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK AT MERCY 1275 YORK AVE NY NY 10065 133954858 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK PHYS-ST CLARE'S 1275 YORK AVE NY NY 10065 133897154 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK REHABILITATION 1275 YORK AVE NY NY 10065 134010371 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK SURGERY GROUP 1275 YORK AVE NY NY 10065 134010372 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK HAUPPAUGE 1275 YORK AVE NY NY 10065 134059247 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM NEUROSURGERY 1275 YORK AVE NY NY 10065 133251621 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 INTERGRATIVE MED 1275 YORK AVE NY NY 10065 542092060 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK-REGIONAL NETWK 1275 YORK AVE NY NY 10065 020594889 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK BASKING RIDGE 1275 YORK AVE NY NY 10065 593801080 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM URGENT CARE GRP 1275 YORK AVE NY NY 10065 651263291 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM CLN GENETICS 1275 YORK AVE NY NY 10065 651263292 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM DEVELOP CHEMO 1275 YORK AVE NY NY 10065 133278548 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK CLINIC PRACTICE 1275 YORK AVE NY NY 10065 510616510 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM BREAST GROUP 1275 YORK AVE NY NY 10065 562568640 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM COLORECTAL GRP 1275 YORK AVE NY NY 10065 562568642 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM DENTAL GRP 1275 YORK AVE NY NY 10065 562568630 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM CLINICAL IMMUNO 1275 YORK AVE NY NY 10065 133278559 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM GASTRIC MIX TMR 1275 YORK AVE NY NY 10065 562568650 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM GYNECOLOGY GRP 1275 YORK AVE NY NY 10065 562568655 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM HEAD & NECK GRP 1275 YORK AVE NY NY 10065 562568656 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM HEPATOBILIARY 1275 YORK AVE NY NY 10065 562568667 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM NEUROSURGERY 1275 YORK AVE NY NY 10065 562568663 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM OPT ABRAMSON 1275 YORK AVE NY NY 10065 562568627 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM OPTHALMIC ONOCO 1275 YORK AVE NY NY 10065 562568675 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM OPHTHALMOLOGY 1275 YORK AVE NY NY 10065 562568669 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM ORTHOPEDIC GRP 1275 YORK AVE NY NY 10065 562568680 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PEDIATRIC SURG 1275 YORK AVE NY NY 10065 562568683 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM CLINICAL PHY 1275 YORK AVE NY NY 10065 133278556 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PLASTIC RECON 1275 YORK AVE NY NY 10065 562568623 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM THORACIC GRP 1275 YORK AVE NY NY 10065 562568677 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM UROLOGY GRP 1275 YORK AVE NY NY 10065 562568638 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PAIN SERVICE 1275 YORK AVE NY NY 10065 651283822 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM DERMATOLOGY GRP 1275 YORK AVE NY NY 10065 133278581 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM ENDOCRINE GRP 1275 YORK AVE NY NY 10065 133278583 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 GASTROENTEROLOGY 1275 YORK AVE NY NY 10065 133278574 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM HEMATOLOGYLYMP 1275 YORK AVE NY NY 10065 133278575 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 CHARITABLE REMAINDER TRUSTS 172 N/A false true false false false false false false true true true false false false false true false false MEMORIAL SLOAN-KETTERING CANCER CENTER L 418273000 COST MEMORIAL SLOAN-KETTERING CANCER CENTER K 13516000 COST MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASE L 40587000 COST MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASE K 355355000 COST SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH L 17000 COST SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH K 115600000 COST SKI REALTY INC L 11472000 COST SKI REALTY INC K 2472000 COST LOUIS V GERSTNER JR GRADUATE SCHOOL K 390000 COST RALPH LAUREN CTR FOR CANCER & PREVENTION Q 2581000 COST RALPH LAUREN CTR FOR CANCER & PREVENTION B 1000000 COST